Immunoglobulin-like domain containing receptor 1 mediates fat-stimulated cholecystokinin secretion

Journal of Clinical Investigation

Volumn 123, Issue 8, 2013, Pages 3343-3352

  Chandra, Rashmi ^a   Wang, Yu ^a   Shahid, Rafiq A ^a   Vigna, Steven R ^a,b   Freedman, Neil J ^a   Liddle, Rodger A ^a,c  

^a Department of Medicine ^*  (Germany)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DURHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CHOLECYSTOKININ; FATTY ACID; GUANINE NUCLEOTIDE BINDING PROTEIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN LIKE DOMAIN CONTAINING RECEPTOR 1; LIPOPROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BLOOD LEVEL; CHO CELL; CONTROLLED STUDY; CYTOKINE RELEASE; INTESTINE CELL; NONHUMAN; PRIORITY JOURNAL; WILD TYPE;

ANIMALS; CALCIUM SIGNALING; CHO CELLS; CHOLECYSTOKININ; CRICETINAE; ENTEROENDOCRINE CELLS; FATTY ACIDS; GENE EXPRESSION; HUMANS; INTESTINE, SMALL; LIPOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, CELL SURFACE; RNA, MESSENGER;

EID: 84881263806     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI68587     Document Type: Article

References (65)

1. Calam J, Ellis A, Dockray GJ. Identification and measurement of molecular variants of cholecystokinin in duodenal mucosa and plasma. Diminished concentrations in patients with celiac disease. J Clin Invest. 1982;69(1):218-225.
2. Liddle RA, et al. Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans. Implications for the physiology of CCK. J Clin Invest. 1989;84(4):1220-1225.
3. Cantor P, et al. The effect of the cholecystokinin receptor antagonist MK-329 on meal-stimulated pancreaticobiliary output in humans. Gastroenterology. 1992;102(5):1742-1751.
4. Wolkowitz OM, Gertz B, Weingartner H, Beccaria L, Thompson K, Liddle RA. Hunger in humans induced by MK-329, a specific peripheral-type cholecystokinin receptor antagonist. Biol Psychiatry. 1990;28(2):169-173.
5. Rehfeld JF, Friis-Hansen L, Goetze JP, Hansen TVO. The biology of cholecystokinin and gastrin peptides. Curr Top Med Chem. 2007;7(12):1154-1165.
6. Woods SC, Seeley RJ, Porte D Jr, Schwartz MW. Signals that regulate food intake and energy homeostasis. Science. 1998;280(5368):1378-1383.
7. Liou AP, et al. The extracellular calcium-sensing receptor is required for cholecystokinin secretion in response to L-phenylalanine in acutely isolated intestinal I cells. Am J Physiol Gastrointest Liver Physiol. 2011;300(4):G538-G546.
8. Wang Y, et al. Amino acids stimulate cholecystokinin release through the Ca2+-sensing receptor. Am J Physiol Gastrointest Liver Physiol. 2011; 300(4):G528-G537.
9. McLaughlin J, Grazia Luca M, Jones MN, D'Amato M, Dockray GJ, Thompson DG. Fatty acid chain length determines cholecystokinin secretion and effect on human gastric motility. Gastroenterology. 1999; 116(1):46-53.
10. Feltrin KL, et al. Comparative effects of intraduodenal infusions of lauric and oleic acids on antropyloroduodenal motility, plasma cholecystokinin and peptide YY, appetite, and energy intake in healthy men. Am J Clin Nutr. 2008; 87(5):1181-1187.
11. Guimbaud R, et al. Intraduodenal free fatty acids rather than triglycerides are responsible for the release of CCK in humans. Pancreas. 1997;14(1):76-82.
12. McLaughlin JT, Lomax RB, Hall L, Dockray GJ, Thompson DG, Warhurst G. Fatty acids stimulate cholecystokinin secretion via an acyl chain length-specific, Ca2+-dependent mechanism in the enteroendocrine cell line STC-1. J Physiol. 1998; 513(1):11-18.
13. Benson RS, Sidhu S, Jones MN, Case RM, Thompson DG. Fatty acid signalling in a mouse enteroendocrine cell line involves fatty acid aggregates rather than free fatty acids. J Physiol. 2002;538(pt 1):121-131.
14. Liou AP, et al. The G-protein-coupled receptor GPR40 directly mediates long-chain fatty acid-induced secretion of cholecystokinin. Gastroenterology. 2011; 140(3):903-912.
15. Glatzle J, et al. Chylomicron components activate duodenal vagal afferents via a cholecystokinin A receptor-mediated pathway to inhibit gastric motor function in the rat. J Physiol. 2003;550(pt 2):657-664.
16. Glatzle J, Darcel N, Rechs AJ, Kalogeris TJ, Tso P, Raybould HE. Apolipoprotein A-IV stimulates duodenal vagal afferent activity to inhibit gastric motility via a CCK1 pathway. Am J Physiol Regul Integr Comp Physiol. 2004;287(2):R354-R359.
17. Hauge H, Patzke S, Delabie J, Aasheim HC. Characterization of a novel immunoglobulin-like domain containing receptor. Biochem Biophys Res Commun. 2004;323(3):970-978.
18. Bihain BE, Yen FT. Free fatty acids activate a high-affinity saturable pathway for degradation of low-density lipoproteins in fibroblasts from a subject homozygous for familial hypercholesterolemia. Biochemistry. 1992;31(19):4628-4636.
19. Yen FT, et al. Molecular cloning of a lipolysis-stimulated remnant receptor expressed in the liver. J Biol Chem. 1999;274(19):13390-13398.
20. Wu J-H, et al. The adaptor protein β-arrestin2 enhances endocytosis of the low density lipoprotein receptor. J Biol Chem. 2003;278(45):44238-44245.
21. Tashiro M, Samuelson LC, Liddle RA, Williams JA. Calcineurin mediates pancreatic growth in protease inhibitor-treated mice. Am J Physiol Gastrointest Liver Physiol. 2004;286(5):G784-G790.
22. Green GM, Levan VH, Liddle RA. Interaction of dietary protein and trypsin inhibitor on plasma cholecystokinin and pancreatic growth in rats. Adv Exp Med Biol. 1986;199:123-132.
23. Liddle RA, Misukonis MA, Pacy L, Balber AE. Cholecystokinin cells purified by fluorescence-activated cell sorting respond to monitor peptide with an increase in intracellular calcium. Proc Natl Acad Sci U S A. 1992;89(11):5147-5151.
24. Mangel AW, et al. Calcium-dependent regulation of cholecystokinin secretion and potassium currents in STC-1 cells. Am J Physiol. 1993; 264(6 pt 1):G1031-G1036.
25. Feng J, et al. Calcium-sensing receptor is a physiologic multimodal chemosensor regulating gastric G-cell growth and gastrin secretion. Proc Natl Acad Sci U S A. 2010;107(41):17791-17796.
26. Reimann F, Habib AM, Tolhurst G, Parker HE, Rogers GJ, Gribble FM. Glucose sensing in L cells: a primary cell study. Cell Metab. 2008;8(6):532-539.
27. Kalogeris TJ, Fukagawa K, Tso P. Synthesis and lymphatic transport of intestinal apolipoprotein A-IV in response to graded doses of triglyceride. J Lipid Res. 1994;35(7):1141-1151.
28. Hussain MM, Kancha RK, Zhou Z, Luchoomun J, Zu H, Bakillah A. Chylomicron assembly and catabolism: role of apolipoproteins and receptors. Biochim Biophys Acta. 1996;1300(3):151-170.
29. Green PH, Tall AR, Glickman RM. Rat intestine secretes discoid high density lipoprotein. J Clin Invest. 1978;61(2):528-534.
30. Forester GP, Tall AR, Bisgaier CL, Glickman RM. Rat intestine secretes spherical high density lipoproteins. J Biol Chem. 1983;258(9):5938-5943.
31. Brunham LR, et al. Intestinal ABCA1 directly contributes to HDL biogenesis in vivo. J Clin Invest. 2006; 116(4):1052-1062.
32. Kindel T, Lee DM, Tso P. The mechanism of the formation and secretion of chylomicrons. Atheroscler Suppl. 2010;11(1):11-16.
33. Abumrad NA, Davidson NO. Role of the gut in lipid homeostasis. Physiol Rev. 2012;92(3):1061-1085.
34. Ji Y, Li X, Tso P. Intestinal fatty acid absorption. Immunol Endocr Metab Agents Med Chem. 2009;9(1):60-73.
35. Attie AD. ABCA1: at the nexus of cholesterol, HDL and atherosclerosis. Trends Biochem Sci. 2007; 32(4):172-179.
36. Anderson RG, Brown MS, Goldstein JL. Role of the coated endocytic vesicle in the uptake of receptor-bound low density lipoprotein in human fibroblasts. Cell. 1977;10(3):351-364.
37. Hussain MM. Structural, biochemical and signaling properties of the low-density lipoprotein receptor gene family. Front Biosci. 2001;6:D417-D428.
38. Yen FT, et al. Identification of a lipolysis-stimulated receptor that is distinct from the LDL receptor and the LDL receptor-related protein. Biochemistry. 1994; 33(5):1172-1180.
39. Kibbey RG, Rizo J, Gierasch LM, Anderson RGW. The LDL receptor clustering motif interacts with the clathrin terminal domain in a reverse turn conformation. J Cell Biol. 1998;142(1):59-67.
40. Magun AM, Mish B, Glickman RM. Intracellular apoA-I and apoB distribution in rat intestine is altered by lipid feeding. J Lipid Res. 1988; 29(9):1107-1116.
41. Rodriguez MD, Kalogeris TJ, Wang XL, Wolf R, Tso P. Rapid synthesis and secretion of intestinal apolipoprotein A-IV after gastric fat loading in rats. Am J Physiol Regul Integr Comp Physiol. 1997; 272(4):R1170-R1177.
42. Fujimoto K, Cardelli JA, Tso P. Increased apolipoprotein A-IV in rat mesenteric lymph after lipid meal acts as a physiological signal for satiation. Am J Physiol. 1992;262(6 pt 1):G1002-G1006.
43. Fujimoto K, Fukagawa K, Sakata T, Tso P. Suppression of food intake by apolipoprotein A-IV is mediated through the central nervous system in rats. J Clin Invest. 1993;91(4):1830-1833.
44. Fujimoto K, et al. Effect of intravenous administration of apolipoprotein A-IV on patterns of feeding, drinking and ambulatory activity of rats. Brain Res. 1993;608(2):233-237.
45. Glatzle J, Kalogeris TJ, Zittel TT, Guerrini S, Tso P, Raybould HE. Chylomicron components mediate intestinal lipid-induced inhibition of gastric motor function. Am J Physiol Gastrointest Liver Physiol. 2002;282(1):G86-G91.
46. Borck G, et al. Loss-of-function mutations of ILDR1 cause autosomal-recessive hearing impairment DFNB42. Am J Hum Genet. 2011; 88(2):127-137.
47. Masuda S, et al. LSR defines cell corners for tricellular tight junction formation in epithelial cells. J Cell Sci. 2011;124(4):548-555.
48. Riazuddin S, et al. Tricellulin is a tight-junction protein necessary for hearing. Am J Hum Genet. 2006; 79(6):1040-1051.
49. Higashi T, et al. Analysis of the 'angulin' proteins LSR, ILDR1 and ILDR2 - tricellulin recruitment, epithelial barrier function and implication in deafness pathogenesis. J Cell Sci. 2013;126(4):966-977.
50. Krieger M, Stern DM. Series introduction: multiligand receptors and human disease. J Clin Invest. 2001; 108(5):645-647.
51. Herz J, Strickland DK. LRP: a multifunctional scavenger and signaling receptor. J Clin Invest. 2001; 108(6):779-784.
52. Sagare AP, Deane R, Zlokovic BV. Low-density lipoprotein receptor-related protein 1: A physiological Aβ homeostatic mechanism with multiple therapeutic opportunities. Pharmacol Ther. 2012; 136(1):94-105.
53. He X, Semenov M, Tamai K, Zeng X. LDL receptor- related proteins 5 and 6 in Wnt/β-catenin signaling: arrows point the way. Development. 2004; 131(8):1663-1677.
54. Ye Z-j, Go G-W, Singh R, Liu W, Keramati AR, Mani A. LRP6 protein regulates low density lipoprotein (LDL) receptor-mediated LDL uptake. J Biol Chem. 2012; 287(2):1335-1344.
55. Valacchi G, Sticozzi C, Lim Y, Pecorelli A. Scavenger receptor class B type I: a multifunctional receptor. Ann N Y Acad Sci. 2011;1229(1):E1-E7.
56. Krieger M. Scavenger receptor class B type I is a multiligand HDL receptor that influences diverse physiologic systems. J Clin Invest. 2001;108(6):793-797.
57. Farrell JJ. Digestion and absorption of nutrients and vitamins. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger & Fordtran's Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management. 8th ed. Philadelphia, Pennsylvania: Saunders Elsevier; 2006: 2147-2197.
58. Chandra R, Samsa L, Vigna S, Liddle R. Pseudopodlike basal cell processes in intestinal cholecystokinin cells. Cell Tissue Res. 2010;341(2):289-297.
59. Schumaker VN, Puppione DL. Sequential flotation ultracentrifugation. Methods Enzymol. 1986; 128:155-170.
60. Terpstra AHM, Pels AE III. Isolation of plasma lipoproteins by a combination of differential and density gradient ultracentrifugation. Fresenius Z Anal Chem. 1988;330(2):149-151.
61. Mihovilovic M, Robinette JB, DeKroon RM, Sullivan PM, Strittmatter WJ. High-fat/high-cholesterol diet promotes a S1P receptor-mediated antiapoptotic activity for VLDL. J Lipid Res. 2007;48(4):806-815.
62. Pitas R, Innerarity T, Weinstein J, Mahley R. Acetoacetylated lipoproteins used to distinguish fibroblasts from macrophages in vitro by fluorescence microscopy. Arterioscler Thromb Vasc Biol. 1981; 1(3):177-185.
63. Innerarity TL, Pitas RE, Mahley RW. Lipoprotein- receptor interactions. Methods Enzymol. 1986; 129:542-565.
64. Liddle RA, Green GM, Conrad CK, Williams JA. Proteins but not amino acids, carbohydrates, or fats stimulate cholecystokinin secretion in the rat. Am J Physiol. 1986;251(2):G243-G248.
65. Takahashi A, Camacho P, Lechleiter JD, Herman B. Measurement of intracellular calcium. Physiol Rev. 1999;79(4):1089-1125.